Vaccines and bioterrorism: Smallpox and anthrax

Journal of Family Practice

Volumn 52, Issue 1 SUPPL., 2003, Pages

  Kimmel, Sanford R ^a   Mahoney, Martin C ^a   Zimmerman, Richard K ^a  

^a NONE

Author keywords

Anthrax; Bioterrorism; Ciprofloxacin; Doxycycline; Smallpox

Indexed keywords

ANTHRAX VACCINE; CIPROFLOXACIN; DOXYCYCLINE; SMALLPOX VACCINE; VACCINE;

ANTHRAX; ANTIBIOTIC THERAPY; BIOLOGICAL WARFARE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; EDEMA; FEVER; HEADACHE; HUMAN; NAUSEA; POSTVACCINAL ENCEPHALITIS; PROPHYLAXIS; REVIEW; SKIN INDURATION; SMALLPOX; VACCINATION; VACCINIA;

EID: 0037232379     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Fenner F. Poxviruses. In: Fields KD, Howley PM, eds. Field's virology. 3rd ed. Philadelphia, PA: Lippincott-Raven, 1996:2673-2683.
2. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations for the Advisory Committee on Immunization - Practices (ACIP). MMWR Recomm Rep 2001;50(RR-10):1-22.
3. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002;346:1300-1308.
4. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999;281:2127-2137
5. Kortepeter M, Christopher G, Cieslak T, et al., eds. Medical management of biological casualties handbook. 4th ed. Fort Detrick, Frederick, MD: U.S. Army Medical Research Institute of Infectious Diseases, 2001. Available at: www.usamriid.army.mil/education/bluebook.html
6. Heiner GG, Fatima N, McCrumb FR Jr. A study of intrafamilial transmission of smallpox. Am J Epidemiol 1971;94:316-326.
7. Franz DR, Jahrling PB, McClain DJ, et al. Clinical recognition and management of patients exposed to biological warfare agents. Clin Lab Med 2001;21:435-73.
8. Mack TM, Thomas DB, Muzaffar Khan M. Epidemiology of smallpox in West Pakistan. II. Determinants of intravillage spread other than acquired immunity. Am J Epidemiol 1972;95:169-177.
9. Fenner F, Arita I, Jezek Z, Ladnyi ID. Smallpox and its eradication. Geneva: World Health Organization, 1988.
10. el-Ad B, Roth Y, Winder A, et al. The persistence of neutralizing antibodies after revaccination against smallpox. J Infect Dis 1990;161:446-448.
11. Mack TM Smallpox in Europe, 1950-1971. J Infect Dis 1972;125:161-169.
12. Stevenson RW, Stolberg SG. President Bush announces smallpox vaccination plan. New York Times online edition, December 13, 2002. Available at: www.nytimes.com/2002/12/13/health/ 13CND-SMALL.html Accessed on December 13, 2002
13. Cherry JD, McIntosh K, Connor JD, et al. Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary percutaneous vaccination. J Infect Dis 1977;135:145-154.
14. Frey SE, Newman FK, Cruz J, et al. Dose-related effects of smallpox vaccine. N Engl J Med 2002;346:1275-1280.
15. Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 2002;346:1265-1274.
16. Lane JM, Neff JM, Millar JD. Complications of smallpox vaccination, 1968. N Engl J Med 1969;281:1201-1208.
17. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 1970;122:303-309.
18. Altman LK, Grady D. Smallpox shot will be free to those who want one. New York Times online edition, December 16, 2002. Available at: http://www.nytimes.com/2002/12/15/health/ 15SMAL.html. Accessed on December 16, 2002.
19. Inglesby TV, O'Toole T, Henderson DA, et al. Anthrax as a biological weapon, 2002. JAMA 2002;287:2236-2252.
20. Swartz MN. Recognition and management of anthrax - an update. N Engl J Med 2001;345:1621-1626.
21. Freedman A, Afonja O, Wu Chang M, et al. Cutaneous anthrax associated with microgangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant. JAMA 2002;287:869-874.
22. Advisory Committee on Immunization Practices. Use of anthrax vaccine in the United States. MMWR Recomm Rep 2000;49(RR-15):1-20.
23. Joellenbeck LM, Zwanziger LL, Durch JS, Strom BL, eds. The anthrax vaccine: Is it safe? Does it work? Washington, DC: National Academy Press, 2002;1-32, 56-82. Available at: http://www.nap.edu/html/anthrax/.
24. Wiesen AR, Littell CT. Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among US Army women. JAMA 2002;287:1556-1560.
25. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001;50:909-919.
26. Mayer TA, Bersoff-Matcha S, Murphy C, et al. Clinical presentation of inhalational anthrax following bioterrorism exposure. JAMA 2001;286:2549-2553.
27. Centers for Disease Control and Prevention, Notice to readers: interim guidelines for investigation of and response to bacillus anthracis exposures. MMWR Morb Mortal Wkly Rep 2001;50:987-990.